Invitae Corporation
NVTA
株式のランク
#35791
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
株価
$0.016
最終同期: 2024-03-11
時価総額
$3.27M
変化（1日）
-5.33%
変化（1年）
5,233.33%
国
US
取引 Invitae Corporation (NVTA)
カテゴリー
Healthcare
Invitae Corporation（NVTA）のEPS
September 2023 時点のEPS TTM: $-5.38
Invitae Corporationの最新の財務報告と株価によると、同社の現在のEPS（TTM）は$-5.38です。2022年末には、EPSは$-13.18で、2021年のEPS$-1.80と増加でした。
Invitae CorporationのEPS履歴（2016から2026まで）
各年末時点のEPS
| 年 | EPS | 変化 |
|---|---|---|
| 2026 (TTM) | $-5.38 | -100.00% |
| 2023 | 0.00 | -100.00% |
| 2022 | $-13.18 | 632.22% |
| 2021 | $-1.80 | -59.73% |
| 2020 | $-4.47 | 68.05% |
| 2019 | $-2.66 | 37.11% |
| 2018 | $-1.94 | -26.79% |
| 2017 | $-2.65 | -12.25% |
| 2016 | $-3.02 | 0.00% |
同様の企業または競合他社のEPS
| 企業 | EPS | EPSの差 | 国 |
|---|---|---|---|
| $18.62 | -446.10% |
US
|
|
| $5.65 | -205.02% |
US
|
|
| $-1.36 | -74.72% |
US
|
|
| - | - |
CN
|
|
| $5.09 | -194.61% |
US
|
